LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
Author(s) -
Kathryn Westendorf,
Stefanie Žentelis,
Lingshu Wang,
Denisa Foster,
Peter Vaillancourt,
Matthew Wiggin,
Erica Lovett,
Robin van der Lee,
J. Hendle,
Anna Pustilnik,
J.M. Sauder,
Lucas Kraft,
Yuri Hwang,
Robert W. Siegel,
Jinbiao Chen,
Beverly A. Heinz,
Richard E. Higgs,
Nicole L. Kallewaard,
Kevin R. Jepson,
Rodrigo Goya,
Maia A. Smith,
David W. Collins,
Davide Pellacani,
Ping Xiang,
Valentine de Puyraimond,
Markéta Řičicová,
Lindsay DeVorkin,
Caitlin Pritchard,
Aoise O’Neill,
Kush Dalal,
Pankaj Panwar,
Harveer Dhupar,
Fabian A. Garces,
Courtney A. Cohen,
John M. Dye,
Kathleen E. Huie,
Catherine V. Badger,
Darwyn Kobasa,
Jonathan Audet,
Joshua J. Freitas,
Saleema Hassanali,
Ina Hughes,
Luis J. Muñoz,
Holly C. Palma,
Bharathi Ramamurthy,
Robert W. Cross,
Thomas W. Geisbert,
Vineet D. Menachery,
Kumari G. Lokugamage,
Viktoriya Borisevich,
Iliana Lanz,
Lisa K. Anderson,
Payal Sipahimalani,
Kizzmekia S. Corbett,
Eun Sung Yang,
Yi Zhang,
Wei Shi,
Tongqing Zhou,
Misook Choe,
John Misasi,
Peter D. Kwong,
Nancy J. Sullivan,
Barney S. Graham,
Tara L. Fernandez,
Carl L. Hansen,
Ester Falconer,
John R. Mascola,
Bryan E. Jones,
Bryan C. Barnhart
Publication year - 2022
Publication title -
cell reports
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2022.110812
Subject(s) - neutralization , epitope , monoclonal antibody , virology , antibody , glycoprotein , covid-19 , coronavirus , biology , microbiology and biotechnology , chemistry , immunology , medicine , disease , infectious disease (medical specialty) , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom